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PreviewsI Siah Substrate!
Proteins are targeted to the E3 RING ubiquitin ligase
Siah through a PxAxVxP degron motif. In this issue
of Structure, House et al. (2006) present the structural
basis by which Siah recognizes its degron with high
affinity and specificity.
The SINA/Siah family of E3 ubiquitin ligases is impli-
cated in the targeted degradation of a diverse range of
proteins including b-catenin and the transcriptional re-
pressor Tramtrack (TTK88) (Boulton et al., 2000; Li
et al., 1997; Liu et al., 2001; Matsuzawa and Reed,
2001; Tang et al., 1997). The majority of the known
SINA/Siah binding proteins possess the heptad se-
quence, Pro-X-Ala-X-Val-X-Pro (where X is not con-
served). Since Siah interaction with proteins bearing
this motif leads many to be ubiquitinated, the motif
has been designated the Siah degron (House et al.,
2003). Aside from substrates such as TIEG1, which inter-
acts directly with Siah (Johnsen et al., 2002), the degron
motif can also facilitate the interaction of Siah with adap-
tor proteins such as SIP (Siah-interacting protein) and
Phyllopod (PHYL), which in turn interact with other pro-
teins to render them substrates of Siah.
Drosophila SINA (seven in absentia) and mammalian
Siah (seven in absentia homologue) possess a domain
architecture consisting of an E2 binding RING domain,
two zinc finger motifs, and a substrate/adaptor binding
domain (SBD). A previous X-ray crystallographic analy-
sis of the Siah SBD revealed an eight-stranded b sand-
wich fold bearing close resemblance to the TRAF do-
main, characteristic of TNF-receptor associated factor
(TRAF) proteins (Polekhina et al., 2002). While the SBD
and TRAF proteins share a common fold, the TRAF do-
main engages its interacting partners through a cleft that
is occluded by a unique helical segment (residues 246–
255) in the Siah SBD. The presence of this segment in the
Siah SBD precludes Siah from engaging adaptor pro-
teins and substrates in the manner employed by TRAFs
(Polekhina et al., 2002). As such, the mechanism by
which the Siah SBD engages its degron motif remained
to be determined.
In this issue of Structure, House et al. (2006) present
an X-ray crystallographic analysis of the Siah1 SBD in
complex with a degron-containing peptide of sequence
Leu-Arg-Pro1-ValX2-Ala3-MetX4-Val5-ArgX6-Pro7-Thr-Val-
Arg from Phyllopod, an adaptor that targets TTK88 to
Siah for ubiquitination (Boulton et al., 2000; Li et al.,
1997; Tang et al., 1997). In the structure, the Phyllopod
peptide engages a hydrophobic cleft on the b-barrel
sandwich opposite the surface where TRAF domains
engage their binding partners. The degron peptide binds
parallel to the outermost b1 strand forming a pseudo ex-
tension of the b sheet. The conserved Pro, Ala, Val, and
Pro residues of the degron orient into the hydrophobic
environment of the cleft. Specific binding of Siah to the
degron is achieved through specific binding pocketsfor the alanine and valine residues in degron positions
3 and 5 that are too small to accommodate bulkier
side chains. In addition, the side chain of proline in de-
gron position 7 packs in a coplanar manner with the
Siah side chain of Trp178. Mutagenesis of key residues
within the binding cleft on Siah was shown to disrupt
binding to PHYL in vitro and to stabilize TIEG1 in vivo,
thus validating the degron recognition mechanism un-
covered in their structure analyses (House et al., 2006).
While not tested, these same mutations in the Siah
SBD would also be predicted to stabilize TKK88, which
requires the adaptor PHYL for targeting and, ultimately,
ubiquitination by Siah.
Degron recognition by the SBD of Siah was indepen-
dently verified in a study by Matsuzawa and colleagues
(Santelli et al., 2005). In that study, the structure of Siah1
in complex with a degron-containing peptide of se-
quence Glu-Lys-Pro1-AlaX2-Ala3-ValX4-Val5-AlaX6-Pro7-
Ile-Thr derived from the adaptor protein SIP was ana-
lyzed using both NMR and crystallographic techniques.
The SIP and PHYL peptides engage the Siah SBD in
a near identical manner. This was somewhat of a sur-
prise considering that the PHYL degron peptide binds
the SBD with an apparent 100-fold higher affinity than
the SIP degron peptide (House et al., 2003; Santelli
et al., 2005). This discrepancy in affinity was rationalized
in part by diversity in peptide residues flanking the core
degron heptad and differences among the variable posi-
tions within the degron itself. In support of this possibil-
ity, the residue at variable position 2 is a valine (Val117)
in PHYL versus alanine (Ala61) in SIP, and mutation of
this position within the PHYL degron to Ala, was shown
to reduce binding in vitro (House et al., 2003). The valine
in degron position 2 is observed to form a hydrophobic
interaction with Val164 and Leu166 in the Siah SBD.
While few residues flanking the core degron heptad
were visualized in either of the Siah-peptide complexes
due to disorder, it was rationalized that degron-flanking
basic residues specific to the PHYL peptide may form
favorable electrostatic interactions with an acidic patch
on the Siah SBD, which could further account for the en-
hanced binding properties of the PHYL peptide (House
et al., 2006; Santelli et al., 2005).
Clearly, differences in residues outside of the con-
served degron positions have a pronounced effect on
binding affinity. However, the relevance of large differ-
ences in binding affinity on Siah-mediated protein ubiq-
uitination remains to be determined. The paper pre-
sented by House et al. (2006) in this issue of Structure
lends insight into the binding mode of Siah with its de-
gron and provides a solid platform for further analysis
into the relationship between SINA/Siah and its corre-
sponding adaptors and substrates.
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A Monotopic Membrane
Protein Goes Solo
Carnitine palmitoyltransferases (CPTs) are part of the
enzymatic system that imports fatty acids into mito-
chondria. The crystal structure of rat CPT-2 by Rufer
et al. (2006) (this issue ofStructure) reveals a Y-shaped
tunnel for binding the CoA and acyl-carnitine sub-
strates and a hydrophobic insert mediatingmembrane
association.
Mitochondrial fatty acid oxidation requires that fatty
acids are imported from the cytosol across the two mi-
tochondrial membranes. This process involves conjuga-
tion of the fatty acids to carnitine in a reaction catalyzed
by carnitine palmitoyltransferase 1 (CPT-1). Acyl-carni-
tine is transported by a specific carrier (Palmieri, 2004)
into the mitochondrial matrix, where it is converted
back to acylCoA through a trans-esterification reaction
carried out by carnitine palmitoyltransferase 2 (CPT-2).
AcylCoA can then be metabolized through the fatty
acid b-oxidation pathway.
Alterations in the enzymatic activities of the fatty acid
translocation system can have profound effects on
energy metabolism. Deficiencies of CPT-1 and CPT-2
caused by genetic defects result in severe disorders that
can be lethal, particularly in cases of early onset (Stanley,
2004). On the other hand, it is known that inhibition of the
CPT enzymes can be of therapeutic value for treatment
of non-insulin-dependent type 2 diabetes, and CPT in-
hibitors are being tested in clinical trials (Giannessi
et al., 2003). The rationale for this approach is that inhibi-
tion of CPTs reduces gluconeogenesis and increases in-
sulin-mediated glucose uptake. The problem is that iso-
form-specific inhibitors are needed in order to decrease
toxicity and to maximize therapeutic efficacy.
In this issue of Structure, Rufer and coworkers de-
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with an inhibitor under clinical evaluation (Rufer et al.,
2006; Giannessi et al., 2003). RatCPT-2 is a monotopic
membrane protein with its hydrophilic domain exposed
on the matrix side of the inner mitochondrial membrane.
Despite its membrane association, the rat enzyme can
be expressed in Escherichia coli with remarkably high
yields. The detergent used for crystallization was n-
octyl-b-D-glucopryranoside, and crystals were obtained
only at a certain detergent concentration (1.5-fold the
critical micelle concentration), underscoring how crucial
the detergent and its concentration are for the crystalli-
zation of membrane proteins that have large hydrophilic
globular domains. The authors employed analytical
ultracentrifugation to study protein oligomerization. In
the case of membrane proteins, this technique is not
straightforward in that it is necessary to achieve so-
called gravitational transparency to compensate for
the presence of the detergent in solution (Lustig et al.,
2000). However, the methodology can be especially
useful for identifying those detergents that make the
protein monodisperse and therefore can facilitate crys-
tallization. The analytical ultracentrifugation experi-
ments showed that ratCPT-2 solubilized in n-octyl-b-
D-glucopryranoside is monodisperse and monomeric.
Consistently, a monomeric state is found also in the
crystals.
As expected on the basis of sequence homology, the
overall structure of ratCPT-2 exhibits the same two-
domain folding topology as carnitine acetyltransferase
(Jogl and Tong, 2003). A notable feature is the architec-
ture of the active site, which is formed by a ‘‘Y-shaped’’
tunnel at the domain interface. The two arms of the ‘‘Y’’
differ in their hydrophobic character forming the CoA-
(more hydrophilic) and acyl binding (hydrophobic) sites,
respectively. Carnitine binding and catalysis of the
trans-esterification reaction occur at the junction of the
two arms. Structure-based sequence alignment con-
firmed that the rat enzyme is highly homologous to
the human protein, and therefore it can serve as a
valid model to understand the differences in substrate
